ELYM Eliem Total Business Assets
Eliem Therapeutics (ELYM) business relies on autonomous development cycles that remain independent of global economic fluctuations and serve as a defensive asset. An intellectual barrier to entry is ensured by exclusive patents and the immense complexity of brain research. The total asset valuations provided below, fixed at 171.13, confirm management transparency and the company leadership's strict adherence to medical regulations.
Analytical breakdowns and data insights for company eliemtx.com (ELYM)
- price and consensus price forecast:
- market capitalization data:
- book capitalization information:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Eliem Therapeutics|ELYM - Long-Term Debt to Equity|Current Liabilities to Capital Eliem Therapeutics Inc.|ELYM - Company Aggregate Debts|Debts to Book Value Eliem Therapeutics Inc.|ELYM - Company Long-Term Debt|Company Short-Term Debt Eliem Therapeutics|Interim Coverage Ratio eliemtx.com
- company profitability and valuation multiples indicators:
Fundamental valuation:ELYM Eliem
Investors are assessing the potential of Eliem Therapeutics (ELYM) through the scale of its resource base, where total assets, reverse-calculated via return on assets (ROA), reflect the actual volume of property relative to generated profits. By analyzing total asset trends (via ROA), one can determine the capitalization efficiency of intellectual property and neuroregulator development costs, which prevents the company from being overvalued prior to the commercialization of epilepsy treatments.
Main competitors
Cumulative Company Assets biogen.com|Aggregate Company Assets Neurocrine Biosciences, Inc.|Total Business Assets RGC (Regencell Bioscience Ltd)|Company Total Assets AXSM|ACAD - Company Assets|Xenon Pharmaceuticals - Cumulative Company Assets|Company Total Assets vikingtherapeutics.com VKTX|SUPN - Aggregate Company Assets|Aggregate Asset Value CPRX (Catalyst Pharma)|Denali Therapeutics Inc (DNLI) - Aggregate Company Assets|Company Assets Harmony Corp (HRMY)|BHVN (Biohaven Ltd.) - Company Total Assets|Company Assets amylyx.com AMLX|Aggregate Company Assets Trevi Therapeutics, Inc. (TRVI)|Aggregate Company Assets PRAX (Praxis Precision Medicines Inc)|Company Total Assets AVXL (Anavex Corp)|Company Total Asset Base CeriBell EEG (CBLL)|Prothena Corporation plc - Company Total Assets|Company Assets Alector, Inc.|Annexon (ANNX) - Aggregate Company Assets|Cumulative Company Assets Omeros|Cumulative Company Assets NGNE|ACIU: Aggregate Asset Value|Cumulative Company Assets VYGR (Voyager Therapeutics)|Aggregate Business Assets NMRA|Company Total Assets SCLX (Scilex)|Aggregate Asset Value TVGN|Alpha Cognition Corp - Company Total Assets|Company Assets Cognition Therapeutics Inc.|Inhibikase Therapeutics (IKT) - Aggregate Company Assets|cassavasciences.com - Aggregate Asset Value|ASRT (Assertio Holdings) - Company Total Assets|Company Total Assets Coya|Aggregate Company Assets Vistagen Therapeutics (VTGN)|OVID: Total Asset Value of Company|Company Total Assets ABOS (Acumen Pharmaceuticals)|cervomed.com (CRVO) - Company Assets|ATHE: Cumulative Company Assets|CLNN - Company Total Assets|PEPG (pepgen.com) - Cumulative Company Assets|JUNS: Aggregate Business Assets|RLMD (Relmada Therapeutics) - Company Total Assets|annovisbio.com (ANVS) - Company Total Asset Base|Company Total Assets GRCE|Cumulative Company Assets Firefly Neuroscience, Inc. AIFF|Aggregate Company Assets Klotho Neurosciences KLTO|Company Total Asset Base NeuroSense Therapeutics Ltd (NRSN)|Reviva Pharmaceuticals - Company Total Assets|Company Assets MetaVia Inc|NeurAxis (NRXS) - Aggregate Company Assets|HSDT (Helius Medical Technologies) - Aggregate Company Assets|Cumulative Company Assets PASG|Company Assets Neuphoria NEUP|Aggregate Company Assets Minerva Neurosciences (NERV)|Cumulative Company Assets athira.com ATHA|Aggregate Company Assets Addex Therapeutics Ltd ADXN|ALZN: Total Business Assets|Cyclerion - Company Total Assets|Company Assets Protagenic Therapeutics|KTTA (pasitheaclinics.com) - Cumulative Company Assets|Cortigent (CRGT) - Company Total Assets|Aggregate Company Assets Avenue Therapeutics, Inc.|BCLI: Aggregate Asset Value|Aggregate Company Assets Cara Therapeutics, Inc (CARA)|CHRO - Company Assets|Company Total Assets ITCI (Intra-Cellular Therapies, Inc.)|longboardpharma.com (LBPH) - Company Assets|MRNS - Aggregate Company Assets|NKGN: Aggregate Company Assets|NRBO: Company Total Assets|SAGE - Company Total Asset Base|SNPX (Synaptogenix, Inc.) - Company Total Assets|Company Assets trevena.com TRVN|Aggregate Company Assets Vigil Neuroscience (VIGL)|Cumulative Company Assets anewmeds.com WENA|Cerevel - Cumulative Company Assets